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Placental chorangioma is a rare tumor with a frequency of 1%. It presents as a solitary nodule or less frequently as multiple 
nodules on the fetal surface of the placenta or within the placental parenchyma. Placental chorangiomas are considered 
clinically significant when >4 cm. Fetal complications associated with placental chorangiomas include polyhydromnios, 
nonimmune fetal hydrops, fetal heart failure, cardiomegaly, intrauterine growth restriction, fetal anemia, thrombocytopenia, 
and fetal demise. Maternal complications such as preeclampsia, preterm delivery, and maternal mirror syndrome are also 
associated with placental chorangiomas. The pathophysiology behind the complications is yet to be fully elucidated, but a 
prominent role for arteriovenous shunting and sequestration of red blood cells and platelets by the chorangioma has been 
postulated. The case presented was a 20‑year‑old primipara at 36 weeks of gestation with live fetus and an incidental finding 
of mixed echogenic mass lesion within the placenta measuring 59 mm × 52 mm. She was planned for elective cesarean 
section but went into spontaneous labor and had uneventful vaginal delivery.
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Introduction
Placental chorangioma is a rare tumor of the placenta with a 
frequency of 1%.[1] It is thought to originate as a malformation 
of the primitive angioblastic tissue of the placenta.[2,3] It 
presents as a solitary nodule or less frequently as multiple 
nodules on the fetal surface of the placenta or within the 
placental parenchyma.[3] Placental chorangiomas are not 
uncommon among primiparas and twin pregnancies and 
their rate increases with maternal age.[3]
Placental chorangiomas are usually asymptomatic and merely 
discovered as incidental findings. However, they can present 
with fetal and maternal complications when they are large 
or multiple in number.[2] Placental chorangiomas vary in size 
and numbers. This variation has a direct relationship with 
both fetal and maternal complications. They are considered 
clinically significant when >4 cm,[4,5] while other workers[6,7] 
suggested a cutoff of ≥5 cm. However, large (≥4–5 cm) or 
multiple chorangiomas have been found to be associated 
with fetal, neonatal, and maternal complications.[8] Clinically 
evident, so-called “giant tumors” of the placenta are 
uncommon with an estimated incidence of 1:3500 and 
1:9000 birth.[9]
Complications associated with placental chorangiomas include 
polyhydramnios, preeclampsia, preterm delivery, nonimmune 
fetal hydrops, fetal heart failure, cardiomegaly, intrauterine 
growth restriction, fetal anemia and thrombocytopenia, fetal 
demise, and maternal mirror syndrome.[7,10-19]
The pathophysiology behind the complications is yet to 
be fully elucidated, but a prominent role for arteriovenous 
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shunting and sequestration of red blood cells and platelets 
by the chorangioma has been postulated.[8] Maternal 
mirror syndrome is defined as maternal edema due to 
fetal hydrops.[15] Its association with large placental 
chorangioma has been reported by several workers.[20-22] 
Other clinical features that can be found in patients with 
maternal mirror syndrome are also found in patients with 
severe preeclampsia which include elevated blood pressure, 
proteinuria, elevated uric acid and creatinine, headache, 
and visual disturbance.[8]
Case Report
She was a 20-year-old primipara who presented for routine 
antenatal follow-up visit with no complaints.
The pregnancy was spontaneously conceived and wanted. 
She booked at 25 weeks of gestation with no complaint. Her 
booking parameters were: weight 80 kg and blood pressure 
120/70 mmHg. Her blood group was O Rhesus D+ and her 
genotype was AS. The Venereal Disease Research Laboratory 
(VDRL) and hepatitis B virus screening were nonreactive and 
Retro viral screening (RVS) was negative.
She had an obstetric ultrasound scan (USS) which showed a 
single live intrauterine fetus in longitudinal lie and breech 
presentation with good cardiac activity. The placenta was 
posterior on the body with homogeneous echo texture. The 
amniotic fluid volume was clear and adequate at estimated 
gestational age of 28 weeks. Expected date of delivery was 
January 14, 2017.
At 36 weeks of gestation, a repeat obstetric USS done, which 
revealed a singleton live intrauterine fetus in longitudinal 
lie and cephalic presentation with good cardiac activity. 
The placenta was postero-fundal. It, however, showed a 
Figure 1: Complex mass of placental chorangioma protruding into the 
amniotic cavity
fairly roundish mixed echogenic mass lesion on its fetal part 
measuring 59 mm × 52 mm in size toward the center of the 
placenta. No separation was seen. The amniotic fluid was 
clear and adequate [Figure 1].
The patient was informed about the condition, and a 
repeat ultrasonography was requested for confirmation. 
She was also counseled for elective cesarean section at 
38 weeks of gestation. The repeat ultrasonography revealed 
the same roundish mass within the placenta measuring 
59 mm × 54 mm. No separation was seen.
She presented with complaints of labor pains at 38 weeks 
of gestation. On examination, she was found to be afebrile, 
not pale, not dehydrated, anicteric, and not cyanosed. 
There was no demonstrable pedal edema and no peripheral 
lymphadenopathy. The abdomen was uniformly enlarged. 
There was no area of tenderness. The liver and spleen were 
not palpably enlarged. The kidneys were not ballotable. 
The symphysis-fundal height was 36 cm. The fetal lie was 
longitudinal in cephalic presentation at left occipito-posterior 
position. The fetal heart rate was 146 beats/min and regular. 
Pelvic examination revealed normal external genitalia; the 
cervix was anterior, soft, and fully effaced. The cervical os 
was 6 cm dilated with membranes bulging. A patograph was 
opened for recording of fetal and maternal vital signs and 
the progress of labor. A wide-bore cannula was inserted. She 
had her blood ready in case of any emergency. The theater 
and the anesthetist were informed. The fetal and maternal 
vital signs were normal.
Four hours after admission into the delivery suite, she had 
the urge to bear down. On review, the cervix was found to 
be fully dilated. She was encouraged to bear down with 
each uterine contraction. She subsequently delivered a live 
Figure 2: Placental chorangioma underneath the chorionic plate near the 
umbilical cord insertion
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female baby weighing 3.2 kg with Apgar scores of 8 and 9 
at 1stand 5th min, respectively. The third stage of labor was 
managed actively. The placenta had a mass on its fetal surface 
which measured about 5 cm × 3 cm in diameter. It was firm 
in consistency [Figures 2 and 3]. The patient and relative 
were counseled on the need for histology. The placenta 
was sent for histology. Estimated blood loss after delivery 
was 150 ml. Histology result showed a well-circumscribed 
mass arising from stem villi. There was proliferation of 
capillary-sized vessels causing expansion of contiguous 
affected villi with associated areas of infarction. Other foci 
showed unremarkable villi.
Serum level of alpha-fetoprotein was normal.
Discussion
Clarke in 1798 first described placental chorangioma as 
hemangiomas.[23] Placental chorangioma is also referred 
to as placental angioma, chorionangioma, angiomyxoma, 
or vascular harmatoma of the placenta.[24] The tumor is 
frequently seen among Caucasians than African-American 
mothers and more often seen with multiple gestation.[25]
Diagnosis is usually by gray-scale sonography and by 
three-dimensional (3D) and 4D ultrasound during the 
antenatal period.[8] In this case, a gray-scale ultrasonography 
was used to make the diagnosis. Here, there was a fairly 
roundish mixed echogenic mass lesion on the fetal surface of 
the placenta. Placental chorangiomas are usually identified 
following USS as an hypoechoic, rounded mass, located 
near the chorionic plate, at times close to the umbilical 
cord insertion. It contains anechoic “cystic” lesion distinctly 
separate from the normal placental tissue. Degenerative 
processes within the mass may appear as heterogeneous 
areas with internal hemorrhage.[2] Chorangiomas may rarely 
appear as pedunculated.[2] Doppler velocimetry often shows 
a low-resistance pulsatile flow within the anechoic “cystic” 
areas representing enlarged vascular channels.[2] Large 
chorangiomas may undergo degenerative changes and 
present as areas of infarction with decreased echogenicity, 
decreased tumor volume, and decreased blood flow on 
color Doppler.[26] Color Doppler imaging (CDI), though 
available in our center, was unfortunately not requested 
for this patient.
Confirmation is by histology of the placental mass. Most 
chorangiomas are localized underneath the chorionic 
plate close to the umbilical cord insertion, protruding 
into the amniotic cavity.[8] This patient manifested with 
this clinical feature. Three histological types of placental 
chorangiomas are reported in the literature. These include 
the angiomatoid type which is characterized by numerous 
blood vessels and the degenerative type and the cellular 
type which have poor vascularization. Majority of the types 
tend to be sporadic.[2]
In low-resource settings, gray-scale ultrasonography is the 
only means of diagnosis. However, in developed nations, 
CDI is used to confirm the presence of vascular channels 
in the tumor, contiguous with the fetal circulation. These 
vascular channels can be used to differentiate chorangiomas 
from other placental lesions such as placental hematoma, 
degenerating fibroids, or partial mole.[19,27-30]
Usually, pregnancies with small chorangiomas progress with 
no complications, and as such do not require interventions.[8] 
Placental chorangiomas >5 cm or multiple in nature are associated 
with maternal, fetal, and neonatal complications, and as such, 
close surveillance is necessary to recognize early signs of serious 
complications and appropriate treatment offered.[8]
Management of symptomatic chorangiomas depends on 
the fetal status and the gestational age. Where pregnancy is 
toward term or fetal lung maturity is ascertain (gestational 
age >34 weeks), expedite delivery via a cesarean section is 
the preferred option. Alternative interventions for preterm 
pregnancies with placental chorangiomas include intrauterine 
blood transfusions of anemic fetus and amnio-drainage.[8] 
In this patient, pregnancy was uncomplicated, but we still 
planned elective cesarean section for her partly due to the 
size of the placental chorangioma coupled with the fear of 
fetal and maternal complications. Spontaneous onset of labor 
with good cervical changes resulted in vaginal birth of a live 
healthy baby before planned cesarean delivery.
Placental chorangiomas are infrequently associated with 
elevated maternal serum alpha-fetoprotein level. Khong and 
Figure 3: Maternal part of the placenta with chorangioma protruding 
(between the index and middle fingers)
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George[31] reported that there was only one case of elevated 
maternal serum alpha-fetoprotein level among the 11 cases 
of placental chorangiomas they so far managed.
Both intrauterine blood transfusion and amnio-drainage do 
not affect and change the underlying pathophysiology of 
arteriovenous shunting within the chorangiomas. Targeted 
treatments to block arteriovenous shunting such as alcohol 
injection,[32] endoscopic laser coagulation, interstitial 
laser therapy,[33,34] and microcoil embolization[33] are being 
considered.
Conclusion
Placental chorangioma is a rare benign tumor. It can be 
diagnosed on routine 2D ultrasonography. Pregnancy with 
placental chorangioma may be carried normally, especially 
when it is solitary and <5 cm in dimension. There is a need 
to draw attention of the sonographer to be extra vigilant 
during USS in order to identify this rare tumor of the placenta.
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